Diseases / Crohn's Disease

Crohn's Disease

Disease
Registered trials
780
Ongoing
107/ 14%
Completed
446

Clinical trial landscape

780 registered studies reference this disease. The split below shows how many are ongoing versus completed per phase.

Phase Total Ongoing Completed Split
Unknown 209 35 124
Phase 3 140 23 86
Phase 2 139 15 81
Not applicable 127 16 69
Phase 4 68 9 33
Phase 1 49 4 32
Phase 1/2 33 3 17
Phase 2/3 11 1 4
Early Phase 1 4 1 0
All phases 780 107 446

Ongoing Completed Balance withdrawn, terminated, or status unreported.

Study records: ClinicalTrials.gov →

Recent developments

FDA Expands Stelara to Pediatric Ulcerative Colitis; Vedolizumab sBLA Under Review empr.com ↗
FDA Approves Stelara for Pediatric Ulcerative Colitis; Vedolizumab Shows Remission in KEPLER Trial fda.gov ↗
How the IRA Could Raise Drug Prices and Limit Access to Convenient Biologics pharmexec.com ↗
AbbVie Q2 Revenue Beats, Guidance Cut on Apogee Acquisition theglobeandmail.com ↗
MASLD Screening and Crohn's Outcomes Highlighted in Two Studies hematologyadvisor.com ↗
AbbVie Posts Record 2025 Revenue of $61.2 Billion, Raises 2026 Guidance on Skyrizi and Rinvoq Growth theglobeandmail.com ↗
End-to-Side Anastomosis May Reduce Crohn’s Recurrence; Early-Onset Colorectal Cancer Burden Rises gastroenterologyadvisor.com ↗
Engineered Extracellular Vesicles Deliver IL-2 and Antibodies for Precision Immunotherapy dovepress.com ↗
Celltrion Presents Remsima SC Post-Hoc Analysis at ECCO 2026 koreabiomed.com ↗
Upadacitinib and Risankizumab Show Comparable Remission in Crohn’s Disease After Anti-TNF Failure dermatologytimes.com ↗

Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.